Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Agid

Showing results (461-470 of 611) with videos related to

Pageof 62
Sort By:
Neurology|December 31, 1997
Clinical and molecular features of spinocerebellar ataxia type 6G Stevanin, A Dürr, G David, et al.
Annals of Neurology|August 12, 1999
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patientsC Ardouin, B Pillon, E Peiffer, et al.
Neurology|September 12, 2000
Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PDJ L Houeto, P B Bejjani, P Damier, et al.
Journal of Neurochemistry|June 1, 1993
Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's diseaseB A Faucheux, E C Hirsch, J Villares, et al.
Advances in Neurology|January 1, 1987
Progressive supranuclear palsy: anatomoclinical and biochemical considerationsY Agid, F Javoy-Agid, M Ruberg, et al.
Journal of Neurochemistry|November 1, 1986
Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmosetP Jenner, H Taquet, A Mauborgne, et al.
Neuroscience|December 1, 1988
Biochemical mapping of cholecystokinin-, substance P-, [Met]enkephalin-, [Leu]enkephalin- and dynorphin A (1-8)-like immunoreactivities in the human cerebral cortexH Taquet, F Javoy-Agid, A Mauborgne, et al.
Neurology|May 9, 2001
Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's diseaseS Descombes, A M Bonnet, U E Gasser, et al.
BMJ (Clinical Research Ed.)|March 5, 1999
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trialM Rösler, R Anand, A Cicin-Sain, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Dopaminergic neurons degenerate by apoptosis in Parkinson's diseaseE C Hirsch, S Hunot, B Faucheux, et al.
Pageof 62

Showing results (461-470 of 611) with videos related to

Sort By:
Pageof 62
Neurology|December 31, 1997
Clinical and molecular features of spinocerebellar ataxia type 6G Stevanin, A Dürr, G David, et al.
Annals of Neurology|August 12, 1999
Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patientsC Ardouin, B Pillon, E Peiffer, et al.
Neurology|September 12, 2000
Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PDJ L Houeto, P B Bejjani, P Damier, et al.
Journal of Neurochemistry|June 1, 1993
Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's diseaseB A Faucheux, E C Hirsch, J Villares, et al.
Advances in Neurology|January 1, 1987
Progressive supranuclear palsy: anatomoclinical and biochemical considerationsY Agid, F Javoy-Agid, M Ruberg, et al.
Journal of Neurochemistry|November 1, 1986
Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmosetP Jenner, H Taquet, A Mauborgne, et al.
Neuroscience|December 1, 1988
Biochemical mapping of cholecystokinin-, substance P-, [Met]enkephalin-, [Leu]enkephalin- and dynorphin A (1-8)-like immunoreactivities in the human cerebral cortexH Taquet, F Javoy-Agid, A Mauborgne, et al.
Neurology|May 9, 2001
Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's diseaseS Descombes, A M Bonnet, U E Gasser, et al.
BMJ (Clinical Research Ed.)|March 5, 1999
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trialM Rösler, R Anand, A Cicin-Sain, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Dopaminergic neurons degenerate by apoptosis in Parkinson's diseaseE C Hirsch, S Hunot, B Faucheux, et al.
Pageof 62